Back to Search
Start Over
Lymphocyte-depleting chemotherapy for aggressive hematologic malignancies in two patients with positive SARS-CoV-2 PCR.
- Source :
-
Leukemia research [Leuk Res] 2021 Jan; Vol. 100, pp. 106473. Date of Electronic Publication: 2020 Nov 13. - Publication Year :
- 2021
- Subjects :
- Adult
COVID-19 blood
COVID-19 diagnostic imaging
COVID-19 genetics
COVID-19 therapy
Female
Humans
Male
Middle Aged
Antineoplastic Combined Chemotherapy Protocols administration & dosage
COVID-19 Nucleic Acid Testing
Hematologic Neoplasms blood
Hematologic Neoplasms diagnostic imaging
Hematologic Neoplasms therapy
Hematologic Neoplasms virology
Lymphocyte Depletion
Lymphoma, B-Cell blood
Lymphoma, B-Cell diagnosis
Lymphoma, B-Cell genetics
Lymphoma, B-Cell therapy
Polymerase Chain Reaction
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma blood
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma diagnosis
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma genetics
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma therapy
SARS-CoV-2 genetics
SARS-CoV-2 metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 1873-5835
- Volume :
- 100
- Database :
- MEDLINE
- Journal :
- Leukemia research
- Publication Type :
- Report
- Accession number :
- 33285314
- Full Text :
- https://doi.org/10.1016/j.leukres.2020.106473